Toll Free: 1-888-928-9744

Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2016

Published: May 1, 2016 | Pages: 50 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2016" provides an overview of Optical Coherence Tomography (OCT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Optical Coherence Tomography (OCT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Optical Coherence Tomography (OCT) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
Table of Contents 2 1.1 List of Tables 4 1.2 List of Figures 5 2 Introduction 6 2.1 Optical Coherence Tomography (OCT) Overview 6 3 Products under Development 7 3.1 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development 7 3.2 Optical Coherence Tomography (OCT) - Pipeline Products by Territory 8 3.3 Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path 9 3.4 Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date 10 3.5 Optical Coherence Tomography (OCT) - Ongoing Clinical Trials 11 4 Optical Coherence Tomography (OCT) - Pipeline Products under Development by Companies 12 4.1 Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development 12 4.2 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development 13 5 Optical Coherence Tomography (OCT) Companies and Product Overview 14 5.1 Canon U.S.A., Inc. Company Overview 14 5.1.1 Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 14 5.2 Cleveland Clinic Hospital Company Overview 16 5.2.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 16 5.3 Compact Imaging Inc. Company Overview 17 5.3.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 17 5.4 Duke University Company Overview 18 5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 18 5.5 George Washington University Company Overview 23 5.5.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 23 5.6 Heidelberg Engineering GmbH Company Overview 25 5.6.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 25 5.7 Leica Microsystems GmbH Company Overview 28 5.7.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 28 5.8 OptoQuest Company Overview 32 5.8.1 OptoQuest Pipeline Products & Ongoing Clinical Trials Overview 32 5.9 Optos Plc Company Overview 33 5.9.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 33 5.10 Sinoora Inc. Company Overview 37 5.10.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 37 5.11 University of California, Berkeley Company Overview 38 5.11.1 University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 38 5.12 University of Rochester Company Overview 40 5.12.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 40 5.13 Volcano Corporation Company Overview 41 5.13.1 Volcano Corporation Pipeline Products & Ongoing Clinical Trials Overview 41 6 Optical Coherence Tomography (OCT)- Recent Developments 43 6.1 Feb 12, 2016: Optovue's AngioVue Imaging System Receives FDA Clearance 43 6.2 Dec 14, 2015: Leica receives FDA approval for EnFocus OCT 43 6.3 Nov 19, 2015: Entellus Medical Enters into Co-Marketing Agreement with Xoran Technologies 44 6.4 Nov 13, 2015: Optovue Showcases Total Cornea Power for Better Eyesight After Cataract Surgery at AAO 2015 44 6.5 Sep 01, 2015: Leica Microsystems now offers Optical Coherence Tomography imaging system for clinical ophthalmology 45 6.6 Aug 25, 2015: Heidelberg Engineering Enters into Licensing Agreement with Massachusetts General Hospital 45 6.7 Jun 10, 2015: Optovue Introduces AngioVue OCTA in Glaucoma 45 6.8 Jun 01, 2015: Leica Microsystems to Acquire Bioptigen 46 7 Appendix 47 7.1 Methodology 47 7.2 About GlobalData 49 7.3 Contact Us 50 7.4 Disclaimer 50
List of Tables
Table 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development 7 Table 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory 8 Table 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path 9 Table 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date 10 Table 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials 11 Table 6: Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development 12 Table 7: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development 13 Table 8: Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 14 Table 9: SPOCT HR - Product Status 15 Table 10: SPOCT HR - Product Description 15 Table 11: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 16 Table 12: Interoperative OCT System - Product Status 16 Table 13: Interoperative OCT System - Product Description 16 Table 14: Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 17 Table 15: MRO Optical Imaging Sensor - Product Status 17 Table 16: MRO Optical Imaging Sensor - Product Description 17 Table 17: Duke University Pipeline Products & Ongoing Clinical Trials Overview 18 Table 18: HH - SDOCT - Product Status 19 Table 19: HH - SDOCT - Product Description 19 Table 20: Microscope Integrated OCT System - Product Status 20 Table 21: Microscope Integrated OCT System - Product Description 20 Table 22: Duke University - Ongoing Clinical Trials Overview 21 Table 23: Microscope Integrated OCT System - Intraoperative OCT Guidance of Intraocular Surgery 22 Table 24: George Washington University Pipeline Products & Ongoing Clinical Trials Overview 23 Table 25: Amplified Bimorph Scanning Mirror System - Product Status 24 Table 26: Amplified Bimorph Scanning Mirror System - Product Description 24 Table 27: Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 25 Table 28: Cataract And Refractive Imaging Platform - Product Status 26 Table 29: Cataract And Refractive Imaging Platform - Product Description 26 Table 30: SPECTRALIS OCT2 Module - OCT Angiography - Product Status 27 Table 31: SPECTRALIS OCT2 Module - OCT Angiography - Product Description 27 Table 32: Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 28 Table 33: DI-SDOCT Imaging System - Product Status 29 Table 34: DI-SDOCT Imaging System - Product Description 29 Table 35: Microscope Integrated Intraoperative OCT - Product Status 30 Table 36: Microscope Integrated Intraoperative OCT - Product Description 30 Table 37: SDOCT Scanner - Product Status 31 Table 38: SDOCT Scanner - Product Description 31 Table 39: OptoQuest Pipeline Products & Ongoing Clinical Trials Overview 32 Table 40: Vectralis - Product Status 32 Table 41: Vectralis - Product Description 32 Table 42: Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 33 Table 43: Falcon I - Product Status 34 Table 44: Falcon I - Product Description 34 Table 45: Falcon II - Product Status 35 Table 46: Falcon II - Product Description 35 Table 47: Lotte - Product Status 36 Table 48: Lotte - Product Description 36 Table 49: Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 37 Table 50: On-chip Spectral Coherence Tomography System - Product Status 37 Table 51: On-chip Spectral Coherence Tomography System - Product Description 37 Table 52: University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 38 Table 53: Directional Optical Coherence Tomography Device - Product Status 39 Table 54: Directional Optical Coherence Tomography Device - Product Description 39 Table 55: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 40 Table 56: Scanning Optical System - Product Status 40 Table 57: Scanning Optical System - Product Description 40 Table 58: Volcano Corporation Pipeline Products & Ongoing Clinical Trials Overview 41 Table 59: Swept Laser Integrated OEM OCT Ophthalmic OCT System - Product Status 42 Table 60: Swept Laser Integrated OEM OCT Ophthalmic OCT System - Product Description 42 Table 61: Glossary 48


List of Figures
Figure 1: Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development 7 Figure 2: Optical Coherence Tomography (OCT) - Pipeline Products by Territory 8 Figure 3: Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path 9 Figure 4: Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date 10 Figure 5: Optical Coherence Tomography (OCT) - Ongoing Clinical Trials 11

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify